For: | Leiting JL, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dessureault S, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Zaidi MY, Patel SH, Ahmad SA, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, LaRocca CJ, Johnston FM, Greer J, Grotz TE. Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative. World J Gastrointest Oncol 2020; 12(7): 756-767 [PMID: 32864043 DOI: 10.4251/wjgo.v12.i7.756] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v12/i7/756.htm |
Number | Citing Articles |
1 |
Chen-Hsi Chiu, Cheng-Wei Lu, Tzu-Yu Lin, Pei-Fu Chen. Abdominal compartment syndrome during intraoperative hyperthermic intraperitoneal chemotherapy following debulking surgery for colorectal cancer: A case report. International Journal of Surgery Case Reports 2024; 123: 110192 doi: 10.1016/j.ijscr.2024.110192
|
2 |
Fatah Tidadini, Catherine Arvieux, Olivier Glehen, Isabelle Sourrouille, Frédéric Marchal, Julio Abba, Brice Malgras, Jean-Louis Quesada, Marc Pocard, Anne-Cécile Ezanno. Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French Expert Centers. Annals of Surgical Oncology 2025; 32(1): 209 doi: 10.1245/s10434-024-16407-1
|
3 |
Xavier Delgadillo-Pfenninger, Eduardo Londoño-Schimmer. Exploring Drug Delivery to the Peritoneum. 2023; : 125 doi: 10.1007/978-3-031-31694-4_6
|
4 |
Alexandra Gangi, Rupen Shah. The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy. Annals of Surgical Oncology 2022; 29(3): 2056 doi: 10.1245/s10434-021-10856-8
|
5 |
Lisa Frankinet, Aditi Bhatt, Vincent Alcazer, Jean-Marc Classe, Jean-Marc Bereder, Pierre Meeus, Christophe Pomel, Francois Mithieux, Karine Abboud, Romauld Wermert, Vincent Lavoue, Frederic Marchal, Olivier Glehen, Naoual Bakrin. Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer. Annals of Surgical Oncology 2023; 30(6): 3287 doi: 10.1245/s10434-023-13242-8
|
6 |
Fabio Carboni, Mario Valle, Marco Vaira, Paolo Sammartino, Orietta Federici, Manuela Robella, Marcello Deraco, Massimo Framarini, Antonio Macrì, Cinzia Sassaroli, Piero Vincenzo Lippolis, Andrea Di Giorgio, Daniele Biacchi, Lorena Martin-Roman, Isabella Sperduti, Dario Baratti. Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis. Cancers 2022; 14(23): 5824 doi: 10.3390/cancers14235824
|
7 |
Wim Ceelen, Jesse Demuytere, Ignace de Hingh. Hyperthermic Intraperitoneal Chemotherapy: A Critical Review. Cancers 2021; 13(13): 3114 doi: 10.3390/cancers13133114
|
8 |
Kurt Van der Speeten, Shigeki Kusamura, Laurent Villeneuve, Pompiliu Piso, Vic J. Verwaal, Santiago González-Moreno, Olivier Glehen. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies. Annals of Surgical Oncology 2024; 31(10): 7090 doi: 10.1245/s10434-024-15513-4
|
9 |
Anne-Cécile Ezanno, Sihame Chkair, Jean-Louis Quesada, Julio Abba, Brice Malgras, Bertrand Trilling, Pierre-Yves Sage, Sophie Bouvet, Alison Foote, Adeline Aime, Olivier Glehen, Marc Pocard, Catherine Arvieux, Fatah Tidadini. Oncological outcomes and hospitalization cost of hyperthermic intraperitoneal chemotherapy (HIPEC) open and closed abdomen techniques: Results from two French expert centers. European Journal of Surgical Oncology 2024; 50(2): 107931 doi: 10.1016/j.ejso.2023.107931
|
10 |
Eduardo Diaz, Isabel Fabra, Emilio Vicente, Yolanda Quijano, Hipolito Duran, Luis Malave, Pablo Ruiz, Giulia Costantini, Valentina Nola, Riccardo Caruso, Valentina Ferri. Closed hyperthermic intraperitoneal chemotherapy with CO2 recirculation system compared with the open Coliseum technique in peritoneal malignity treatment. Surgical Oncology 2023; 46: 101901 doi: 10.1016/j.suronc.2023.101901
|
11 |
Mukur Dipi Ray, Kunal Dhall. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies – An evidence-based review. Current Problems in Cancer 2021; 45(6): 100737 doi: 10.1016/j.currproblcancer.2021.100737
|
12 |
Joyce Y. Wang, Maya Gross, Renata R. Urban, Soledad Jorge. Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer. Current Treatment Options in Oncology 2024; 25(3): 313 doi: 10.1007/s11864-023-01171-3
|
13 |
S. Hassan, S. Dritsas, S.T. O'Dwyer, O. Aziz, P. Sutton, X. Wang, R. Fish, A.G. Renehan, M. Wilson, C. Selvasekar, H. Clouston, J. Wild, M. Mathur. Open versus Closed technique for administration of heated intraperitoneal chemotherapy (HIPEC): Morbidity and Mortality outcomes from a high-volume centre. European Journal of Surgical Oncology 2023; 49(9): 106924 doi: 10.1016/j.ejso.2023.04.023
|
14 |
Alisar M. Aljundi, Rachel C. Wolfe. Hyperthermic Intraperitoneal Chemotherapy. Journal of PeriAnesthesia Nursing 2024; 39(4): 688 doi: 10.1016/j.jopan.2024.05.016
|
15 |
Felix Gronau, Linda Feldbruegge, Frauke Oberwittler, Santiago Gonzalez-Moreno, Laurent Villeneuve, Clarisse Eveno, Olivier Glehen, Shigeki Kusamura, Beate Rau. HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques. Journal of Clinical Medicine 2022; 11(5): 1456 doi: 10.3390/jcm11051456
|
16 |
Hisham Abdel Mageed, Kurt Van Der Speeten, Paul Sugarbaker. The many faces of intraperitoneal chemotherapy. Surgical Oncology 2022; 40: 101676 doi: 10.1016/j.suronc.2021.101676
|
17 |
Zhitao Cai, Boyuan Liu, Qing Cai, Jingxin Gou, Xing Tang. Advances in microsphere-based therapies for peritoneal carcinomatosis: challenges, innovations, and future prospects. Expert Opinion on Drug Delivery 2025; 22(1): 31 doi: 10.1080/17425247.2024.2439462
|
18 |
Aditi Bhatt, Ignace de Hingh, Kurt Van Der Speeten, Martin Hubner, Marcello Deraco, Naoual Bakrin, Laurent Villeneuve, Shigeki Kusamura, Olivier Glehen. HIPEC Methodology and Regimens: The Need for an Expert Consensus. Annals of Surgical Oncology 2021; 28(13): 9098 doi: 10.1245/s10434-021-10193-w
|
19 |
Nolan M. Winicki, Jonathan B. Greer. Is Hyperthermic Intraperitoneal Chemotherapy Appropriate for Colon Cancer?. Advances in Surgery 2024; 58(1): 49 doi: 10.1016/j.yasu.2024.04.004
|
20 |
Mingchun Mu, Zhaolun Cai, Xueting Liu, Bo Zhang, Zhixin Chen, Jiankun Hu, Kun Yang. Intraperitoneal chemotherapy for primary gastric cancer. Cochrane Database of Systematic Reviews 2023; 2023(9) doi: 10.1002/14651858.CD015698
|
21 |
Hanna Garnier, Maciej Murawski, Tomasz Jastrzebski, Katarzyna Pawinska-Wasikowska, Walentyna Balwierz, Katarzyna Sinacka, Wojciech Gorecki, Ewa Izycka-Swieszewska, Piotr Czauderna. Case Report: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Application in Intraperitoneally Disseminated Inflammatory Myofibroblastic Tumor and in the Youngest Patient in the World: New Indication and Modification of Technique. Frontiers in Surgery 2021; 8 doi: 10.3389/fsurg.2021.746700
|
22 |
Maria F. Ramirez, Juan Jose Guerra-Londono, Pascal Owusu-Agyemang, Keith Fournier, Carlos E. Guerra-Londono. Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1062158
|
23 |
Megan M. Harper, Joseph Kim, Prakash K. Pandalai. Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies. Journal of Clinical Medicine 2022; 11(10): 2840 doi: 10.3390/jcm11102840
|
24 |
Eliza W. Beal, Shruthi Srinivas, Chengli Shen, Alex Kim, Fabian M. Johnston, Jonathan Greer, Daniel E. Abbott, Courtney Pokrzywa, Mustafa Raoof, Travis E. Grotz, Jennifer L. Leiting, Keith Fournier, Sean Dineen, Benjamin Powers, Jula Veerapong, Anai Kothari, Ugwuji Maduekew, Shishir Maithel, Gregory C. Wilson, Sameer H. Patel, Laura Lambert, Sherif Abdel-Misih, Jordan M. Cloyd. Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative. Annals of Surgical Oncology 2023; 30(3): 1840 doi: 10.1245/s10434-022-12753-0
|
25 |
Niki Christou, Clément Auger, Serge Battu, Fabrice Lalloué, Marie-Odile Jauberteau-Marchan, Céline Hervieu, Mireille Verdier, Muriel Mathonnet. Intraperitoneal Chemotherapy for Peritoneal Metastases: Technical Innovations, Preclinical and Clinical Advances and Future Perspectives. Biology 2021; 10(3): 225 doi: 10.3390/biology10030225
|
26 |
Sanae El Harane, Bochra Zidi, Nadia El Harane, Karl-Heinz Krause, Thomas Matthes, Olivier Preynat-Seauve. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine. Cells 2023; 12(7): 1001 doi: 10.3390/cells12071001
|
27 |
L. Martín Román, P. Lozano, D. Baratti, S. Kusamura, M. Deraco, W. Vásquez, L. González Bayón. Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC. Annals of Surgical Oncology 2022; 29(12): 7553 doi: 10.1245/s10434-022-12060-8
|